Raising the bar for market authorisation of new drugs

Naci, Huseyin ORCID: 0000-0002-7192-5751, Cylus, Jonathan ORCID: 0000-0001-8269-1578, Vandoros, Sotiris, Sato, Azusa and Perampaladas, Kumar (2012) Raising the bar for market authorisation of new drugs. The BMJ, 345. e4261-e4261. ISSN 1756-1833

Full text not available from this repository.

• Author

Abstract

Huseyin Naci and colleagues find that raising evidence standards for market entry of new drugs could have numerous benefits, including providing incentives for development in therapeutic areas with few treatment options.

Item Type:	Article
Official URL:	http://www.bmj.com/
Additional Information:	© 2012 BMJ Publishing Group Ltd.
Divisions:	LSE Health Lifecourse, Ageing & Population Health
Subjects:	R Medicine > RA Public aspects of medicine
Date Deposited:	23 Aug 2012 15:12
Last Modified:	01 Feb 2025 05:15
URI:	http://eprints.lse.ac.uk/id/eprint/45547

Actions (login required)

View Item